List of participants

back to list

Genom,ics Unit_Madrid Science ParK

Faraday 7
ZIP Code

Company Profile:
The PCM Technology Development Units (TDUs) offer a wide range of scientific services to research groups, hospitals, and companies that are aimed at positioning their operations in the best quality standards.
Similarly, PCM carries out scientific and methodological research in collaboration with other R&D groups, promoting training of both technicians and Unit users and serving as a meeting point between the university environment's scientific development, the public, and technological demand in the private sector, optimizing available resources to achieve competitive research. Its highly qualified human resources employ the most advanced and innovative technology and equipment in the areas of:

 Genomics
 Proteomics
 Molecular Interactions
 Industrial biotransformation
 Materials Microanalysis

Far from having a small impact on the area, PCM works mainly with scientific-technical knowledge generated in the public sector that is restored when getting in contact with the productive fabric.

Genomics Unit of PCM offers a High throughput massive sequencing technologies for human health.

What we offer:
 Use of novel high throughput technologies for the diagnosis of genetic diseases based on exome sequencing. The exome is the part of the genome directly involved in most of the relevant biological and pathological processes. DNA ultrasequencing coupled to exome-enrichment techniques allows a cost-effective, quick and efficient way of studying genetic variability associated to disease. Scanning of polymorphisms in familiar trees may allow a deep understanding of the genetic basis of diseases.

 Use of long-read large-scale sequencing data to study the variability of microbial flora, both by ultra-deep ribosomal coding DNA, based on amplicon sequencing as well as by genome-wide approaches based on shot-gun sequencing or RNA sequencing.


The Unit has provided support, through its services, to more than 450 research projects. As well, it has participated in the project: “Study of protection mechanisms against HIV-1 and application of new technologies for evaluating genetic, immunological and virological markers to appraise the efficiency of immune responses induced by therapeutic vaccines” (FIS PI061255) MR: uardo Fernández-Cruz Pérez, Immunology Service. “Gregorio Marañón” University Hospital. Project participants: Jesús García Cantalejo and Ricardo Ramos.
4. What are the main advantages of your solutions over other solutions? (Faster, cheaper, easier to install and/or maintain, etc.)

What are we looking for:
We are looking for any company, hospital or public research organisation interested in our technology, in order to make joint research, participate in international research project or achieve a collaborative research agreement.

  • ] Pharmaceutics
  • ] Biology/Biotechnology

Collaboration sought:
  • Commercial Agreement
  • FP7 Project
  • Research and development
  • Technical Co-operation


Mr Natalia Aldaba

back to list


© 2011 ConVerve GmbH | all rights reserved